News
LENZ Therapeutics is progressing rapidly with its LNZ100 for presbyopia, aiming for a 2025 U.S. launch in a market valued at ...
A free account provides you access to a limited number of free articles each month, plus newsletters, job postings, salary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback